Respiratory: Pain Respiratory Pain
Conditions
Interventions
Consenting patients will receive either 2% Lignocaine or placebo (0.9% saline). The preparation received will be distributed by a randomised numbered system dictated by the pharmacy department of the
Sponsors
Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: All patients attending for fine needle aspiration of the thyroid gland to the Ipswich Hospital NHS Trust will be asked to participate.
Exclusion criteria
Exclusion criteria: Patients who have had a previous fine needle aspiration biopsy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of aspirations attainable (up to 5) and success in obtaining adequate samples. | — |
Countries
United Kingdom
Outcome results
None listed